The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 21, 2018
Filed:
Sep. 21, 2006
John Foekens, Rotterdam, NL;
John W. Martens, Rotterdam, NL;
Serenella Eppenberger-castori, Riehen, CH;
Vincent Vuaroqueaux, Hesingue, FR;
Frederique Spyratos, La Celle St-Cloud, FR;
Nadia Harbeck, Otterfing, DE;
Manfred Schmitt, Munich, DE;
Heinz Hoefler, Munich, DE;
Sabine Maier, Brussels, BE;
Gunter Weiss, Berlin, DE;
Ralf Lesche, Berlin, DE;
Thomas Hildmann, Berlin, DE;
Achim Plum, Berlin, DE;
John Foekens, Rotterdam, NL;
John W. Martens, Rotterdam, NL;
Serenella Eppenberger-Castori, Riehen, CH;
Vincent Vuaroqueaux, Hesingue, FR;
Frederique Spyratos, La Celle St-Cloud, FR;
Nadia Harbeck, Otterfing, DE;
Manfred Schmitt, Munich, DE;
Heinz Hoefler, Munich, DE;
Sabine Maier, Brussels, BE;
Gunter Weiss, Berlin, DE;
Ralf Lesche, Berlin, DE;
Thomas Hildmann, Berlin, DE;
Achim Plum, Berlin, DE;
THERAWIS DIAGNOSTICS GMBH, Munich, DE;
Abstract
The present invention relates to methods for predicting the outcome of anthracycline treatment of cell proliferative disorder patients. This is achieved by determining the expression level of at least one gene selected from the group consisting of PITX2; TFF1 and PLAU. The invention also relates to sequences, oligonucleotides and antibodies which can be used within the described methods.